Answers are grounded in this paper and cite their sources.
Background: Instrumented human-movement assessment can be integrated with neurological examination and clinical scales to objectify functional deficits and quantify rehabilitation-related change. We evaluated a diagnostic-integration pathway in which TecnoBody ProKin posturography and Xsens MVN Awinda gait analysis were embedded in routine hospital neurorehabilitation as objective functional-diagnostic and outcome-monitoring tools. Methods: This manuscript reports a secondary exploratory longitudinal analysis of prospectively acquired routine-care measurements. The publication dataset comprised 151 participants with baseline posturography (stroke, n = 90; Parkinson’s disease, n = 38; multiple sclerosis [MS], n = 23); baseline gait data were available for 107. Diagnosis-specific Gaussian random-intercept models were fitted by restricted maximum likelihood with categorical time, and global time effects and PRE-to-POST contrasts were controlled using Benjamini–Hochberg False Discovery Rate (FDR) correction. Results: In stroke, dynamic open-eye Total Stability Index (TSI) showed an FDR-significant global time effect (Wald χ2(4) = 18.07, p = 0.00120, q = 0.00717), with lower model-estimated TSI at POST 2 (−1.46°, q = 0.0121; standardized effect = −0.50) and POST 3 (−1.92°, q = 0.0121; standardized effect = −0.65). Stroke cadence showed a global longitudinal signal in the full model (q = 0.0443); however, this finding did not remain FDR-significant in a sensitivity analysis excluding the sparsely populated POST 4 milestone (q = 0.139) and was therefore interpreted as exploratory. In Parkinson’s disease, the POST 1 TSI contrast was supportive only because the endpoint-level global test did not survive FDR correction. MS follow-up was insufficient for strong longitudinal inference, particularly for gait, and is interpreted primarily as a feasibility/data-availability finding. Conclusions: Diagnostic integration of ProKin and Xsens into routine neurorehabilitation was feasible and generated objective patient-specific trajectories for balance and gait outcome monitoring. The measurements can objectify rehabilitation-related functional change, but the uncontrolled design does not establish causal treatment efficacy, and clinically meaningful individual-change thresholds remain to be validated.
No takes yet. Share an insight, caveat, or question.
Törő et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: